Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Blood Protein Disorders » Paraproteinemias
Diseases [C] » Immune System Diseases [C20] » Immunoproliferative Disorders » Paraproteinemias
Description
A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin. MeSH
Hierarchy View
Subtype Terms (8)
Cryoglobulinemia
9 approved drugs
Immunoglobulin Light-chain Amyloidosis
55 drugs (41 approved, 14 experimental)
Monoclonal Gammopathy of Undetermined Significance
23 drugs (19 approved, 4 experimental)
Multiple Myeloma
918 drugs (315 approved, 603 experimental)
POEMS Syndrome
9 drugs (7 approved, 2 experimental)
Smoldering Multiple Myeloma
36 drugs (26 approved, 10 experimental)
Waldenstrom Macroglobulinemia
177 drugs (96 approved, 81 experimental)
Phase 4 Indicated Drugs (1)
Phase 3 Indicated Drugs (1)
Phase 2 Indicated Drugs (14)
Phase 1 Indicated Drugs (1)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (23)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
